Pentostatin
Records for this ingredient, by country (identity only).
ATC L01XX08 · 6 markets · 7 records
AU 2 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionHospira Nipent (Pentostatin for Injection) 10 mgHospira Nipent (pentostatin for injection) 10 mg US
US 1 records · 1 shown of 1
- 2 mg per mL / per unit basis not statedinjectionNipent
GB 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionNipent 10mg powder for solution for injection vials
ES 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionNipent
FR 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionNIPENT 10 mg, poudre pour solution pour injection, poudre pour solution pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | AU | ES | FR |
|---|---|---|---|---|---|
| 10 mg per mL / per unit basis not stated cannot compare injection | Nipent 10mg powder for solution for injection vials | Hospira Nipent (Pentostatin for Injection) 10 mg Hospira Nipent (pentostatin for injection) 10 mg US | Nipent | NIPENT 10 mg, poudre pour solution pour injection, poudre pour solution pour perfusion | |
| 2 mg per mL / per unit basis not stated cannot compare injection | Nipent |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.